Bausch & Lomb's Revenue Momentum Meets the Test of Raised Expectations

Bausch + Lomb Corporation (BLCO) reports second-quarter 2026 earnings before the market opens on July 29, 2026, with analysts expecting $0.16 per share—more than double the year-ago result. The central question: can the eye health company sustain the momentum from three consecutive earnings beats, or will the stock's recent technical strength face a test as options traders price in a 4.61% expected move?

Part 1: Earnings Preview

Bausch + Lomb Corporation is a global eye health company focused on contact lenses, pharmaceuticals, and surgical products, serving both consumer and professional markets. The company's diversified portfolio spans vision care products and ophthalmic pharmaceuticals, making it a key player in the growing eye health sector.

Analysts expect BLCO to report $0.16 per share for the second quarter ending June 2026, with 5 estimates ranging from $0.14 to $0.21. The company most recently reported $0.08 per share for the first quarter of 2026, beating estimates by 33.33%. Compared to the $0.07 reported in the same quarter last year, the consensus represents +128.57% year-over-year growth—a dramatic acceleration that reflects both operational improvements and easier comparisons.

Three key themes define this earnings story:

1. Margin Expansion and Operational Leverage: The sharp year-over-year EPS growth estimate suggests BLCO is successfully converting revenue into bottom-line results. Investors will scrutinize whether cost controls and manufacturing efficiencies are sustainable or if one-time benefits are inflating the comparison.

2. Vision Care Demand Trajectory: As a pure-play eye health company, BLCO's performance hinges on contact lens volumes and pharmaceutical sales. The post-pandemic normalization of eye care visits and elective procedures remains a critical driver, and any commentary on demand trends will move the stock.

3. Guidance and Full-Year Outlook: With full-year 2026 EPS estimates at $0.82 (up +90.70% from prior-year levels), management's confidence in sustaining this growth trajectory will be paramount. Any adjustment to guidance—particularly for the second half—could overshadow the quarterly beat-or-miss.

Analyst commentary ahead of the release has been cautious. The consensus rating of 3.43 (between Hold and Buy) reflects a divided Street, with 9 Hold ratings dominating the 14 total recommendations. The $18.50 mean price target implies modest upside, suggesting analysts are waiting for proof that the earnings acceleration is durable rather than cyclical.

Part 2: Historical Earnings Performance

Bausch + Lomb has delivered three consecutive earnings beats, demonstrating improving execution. The company reported $0.07 in Q2 2025 (beating by +16.67%), $0.18 in Q3 2025 (beating by +12.50%), and $0.08 in Q1 2026 (beating by +33.33%). The sole miss came in Q4 2025, when BLCO reported $0.32 against a $0.35 estimate, a -8.57% shortfall.

The pattern reveals a company that has regained its footing after the Q4 stumble. The magnitude of beats has been expanding—from mid-teens percentage beats to a 33% upside surprise last quarter—suggesting either conservative guidance or genuine operational momentum. The Q4 miss appears to be an anomaly rather than a trend reversal, as the company immediately returned to form in Q1 2026.

Heading into tomorrow's report, the $0.16 consensus represents a significant step-up from the $0.08 delivered last quarter, testing whether BLCO can maintain its beat streak while navigating tougher sequential comparisons. The recent track record supports optimism, but the bar has been raised.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

BLCO reports before the market open, meaning Day 0 captures the first full trading session of market reaction, while Day +1 reflects follow-through sentiment.

Bausch + Lomb's post-earnings price behavior shows significant volatility on the day of the report, with an average absolute Day 0 move of 3.83% and an average intraday range of 7.34%. The direction has been mixed: the stock plunged -15.74% on April 30, 2025, and dropped -6.42% on July 30, 2025, but also posted gains of +2.07% (July 2024) and +1.78% (October 2025).

Day +1 follow-through is more muted, averaging 1.52% with a 3.99% range, suggesting most of the price discovery happens in the immediate reaction. The April 2025 collapse stands out as an outlier—likely tied to a guidance cut or significant miss—while more recent reports have produced smaller, more contained moves. Investors should prepare for a volatile open tomorrow, with the stock historically swinging within a 7%–8% range on earnings day.

Part 2.2: Options Market Expected Move

The options market is pricing a 4.61% expected move for the August 21 expiration, which sits above the 3.83% average historical Day 0 move but well below the 7.34% average intraday range. This suggests options traders are anticipating a meaningful reaction, though not as extreme as some past earnings events like the April 2025 collapse.

Part 3: What Analysts Are Saying

Analysts maintain a cautious stance on Bausch + Lomb, with a consensus rating of 3.43 (between Hold and Buy) across 14 recommendations. The breakdown shows 3 Strong Buys, 1 Moderate Buy, 9 Holds, 1 Moderate Sell, and 0 Strong Sells—a distribution heavily weighted toward the middle, reflecting uncertainty about the sustainability of recent earnings momentum.

The $18.50 mean price target implies +11.4% upside from the current $16.61 price, with estimates ranging from a $16.00 low to a $21.00 high. This relatively tight range suggests limited conviction in either direction, as analysts await proof that the operational improvements driving EPS growth are structural rather than temporary.

Sentiment has remained unchanged over the past month, with no shift in the average recommendation or the distribution of ratings. The stability suggests the Street is in wait-and-see mode, unwilling to upgrade ahead of the report but also not turning more negative. The 9 Hold ratings dominate the conversation, indicating most analysts view BLCO as fairly valued at current levels and are looking for the company to deliver multiple quarters of consistent execution before upgrading their stance.

Part 4: Technical Picture

Bausch + Lomb enters earnings with strengthening technical momentum. The Barchart Technical Opinion has surged to a 40% Buy signal, up sharply from 24% Sell last week and 8% Sell a month ago—a dramatic reversal that reflects improving short-term price action.

Timeframe Analysis:

• Short-term (100% Buy): Strong buy signal indicates near-term momentum is decisively positive heading into the report
• Medium-term (50% Sell): Moderate sell signal suggests intermediate-term resistance or consolidation pressures remain
• Long-term (50% Buy): Moderate buy signal reflects a balanced longer-term trend with no clear directional bias

Trend Characteristics: The Weak Average trend environment suggests momentum is building but lacks conviction, leaving the stock vulnerable to sharp reversals on disappointing news.

The stock is trading at $16.61, positioned above all major moving averages: the 5-day ($16.20), 10-day ($16.23), 20-day ($16.43), 50-day ($15.90), 100-day ($16.08), and 200-day ($16.31). This alignment indicates a bullish short-term setup, though the proximity to the 20-day and 200-day averages suggests limited cushion if the report disappoints.

The technical picture is supportive but fragile. BLCO has broken above its key moving averages and generated a strong short-term buy signal, but the weak trend strength and mixed medium-term reading suggest the rally lacks deep conviction. The $16.43 20-day moving average now serves as immediate support, while the $18.50 analyst price target represents the next upside hurdle. A beat-and-raise scenario could propel the stock toward the high-end $21.00 target, but any disappointment risks a quick retreat to the $15.90 50-day average, where the recent rally began.